Nippon Chemiphar Parts Ways With Ranbaxy; Takes Over Generics Venture
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based Nippon Chemiphar Dec. 8 announced a dissolution of its partnership with India's Ranbaxy Laboratories. A generic drug joint venture established by the two will become a Nippon Chemiphar wholly owned subsidiary